Checked.be
Active
BE 0748.402.807Private limited company
FourD
Rue de l'Espinette 35 ·7190 Ecaussinnes, Belgium· 6 yrs active
Sector: Physiotherapy
(86951)
Conclusion
FourD has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €40k and a net result of €1k. Equity is growing by ~15.5% per year across the filed fiscal years. Its solvency ranks better than 27% of 19894 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Based on the State Gazette, CBE and 4 annual accounts.
Key figures
| Equity | €40k |
| Net result | €1k |
| Better than sector | 27% |
| Active | 6 yrs |
Financial profile
66
/ 100
Strong profile, led by stability.
All 5 axes are computed from data Checked has read.
Health
87
Profitability
14
Solvency
75
Growth
52
Stability
100
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
More than 3 years active
Founded in 2020, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
87
/ 100
Excellent
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€4k
estimate, not credit advice
Score history
48
2021
94
2022
63
2023
87
2024
purely financial, excl. current insolvency signals
Score components
Liquidity
Current ratio 1.63 (≥ 1.5)
+10
Quick ratio
Quick ratio 1.63 (≥ 1.0)
+5
Leverage
Debt/equity 1.54 (< 2.0)
+3
Profitability
ROE 3%
+3
Interest coverage
Interest coverage 39.5× (≥ 3×)
+8
Profit trend
Net profit up YoY
+5
Equity growth
Equity growing YoY
+3
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.
Financial overview
Annual accounts filed on 08-10-2025 with the NBB · fiscal year 2024 · micro schema
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing
Equity: growth of ~15.5%/year over 4 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2024 · NACE 86, Human health activities · compared within the same schema type (micro schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 39.3% | 67.5% | |
| Net result | €1k | €59k | |
| Equity | €40k | €149k | |
| Gross operating margin | €50k | €114k | |
| Staff costs | €34k | €30k |
€143k
-
21-24
€16k
+4.4%
21-24
€1k
-
21-24
€18k
+55.7%
21-24
€101k
-2.9%
21-24
€40k
+1.6%
21-24
€29k
-13.1%
21-24
1
0.0%
21-24
€34k
+70.8%
21-24
€3k
-51.3%
21-24
€61k
-5.6%
21-24
€45k
+16.6%
21-24
€16k
-38.4%
21-24
1.63
-11.7%
21-24
1.63
-11.7%
21-24
39.3%
+4.6%
21-24
1.54
-7.1%
21-24
2.9%
-
21-24
1.1%
-
21-24
23.8%
-
21-24
29.4%
-
21-24
39.50
+24.2%
21-24
Figures by fiscal year and ratios
Change versus the prior fiscal year, coloured by direction (green = favourable).
| Fiscal year | 2024 Δ | 2023 Δ | 2022 Δ | 2021 Δ |
|---|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - |
| EBITDA | +4.4% | -64.2% | -10.6% | - |
| Net profit | - | - | -3.4% | - |
| Cash flow | +55.7% | -71.7% | -4.3% | - |
| Staff costs | +70.8% | +335.0% | - | - |
| Income taxes | - | - | - | - |
| Dividends | - | - | - | - |
| Total assets | -2.9% | +23.9% | +17.2% | - |
| Equity | +1.6% | -0.1% | +655.5% | - |
| Debt | -5.6% | +44.8% | -32.6% | - |
| of which ≤ 1y | +16.6% | +15.6% | -49.6% | - |
| of which > 1y | -38.4% | +190.7% | - | - |
| Working capital | -13.1% | +1.8% | - | - |
| Employees (FTE) | - | 0.0% | - | - |
Ratios (computed)
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Current ratio | 1.63 | 1.85 | 1.96 | 0.76 |
| Quick ratio | 1.63 | 1.85 | 1.96 | 0.76 |
| Working capital ratio | 28.2% | 31.5% | 38.4% | -22.5% |
| Solvency | 39.3% | 37.6% | 46.6% | 7.2% |
| Debt / equity | 1.54 | 1.66 | 1.15 | 12.83 |
| Long-term debt ratio | 0.41 | 0.67 | 0.23 | - |
| Interest coverage | 39.50 | 31.81 | 33.64 | 4313.21 |
| Gross margin | - | - | 37.7% | - |
| Net margin | - | - | 23.8% | - |
| ROA | 1.1% | 0.0% | 40.4% | 49.1% |
| ROE | 2.9% | -0.1% | 86.8% | 678.6% |
| EBITDA margin | - | - | 29.4% | - |
| Days sales outstanding | - | - | 128d | - |
| Days payable outstanding | - | 22d | 11d | 2d |
| Inventory turnover | - | - | - | - |
| Days inventory (DSI) | - | - | - | - |
Balance-sheet composition 2024
Full annual accounts (22 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Balance sheet, Assets | |||||
| TOTAL ASSETS | 20/58 | €101k | €104k | €84k | €72k |
| Fixed assets | 21/28 | €27k | €33k | €18k | €21k |
| Tangible fixed assets | 22/27 | €27k | €33k | €18k | €21k |
| Current assets | 29/58 | €74k | €72k | €66k | €50k |
| Amounts receivable within one year | 40/41 | €47k | €43k | €50k | €37k |
| Cash & bank | 54/58 | €27k | €28k | €16k | €13k |
| Balance sheet, Equity & liabilities | |||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €101k | €104k | €84k | €72k |
| Equity | 10/15 | €40k | €39k | €39k | €5k |
| Accumulated profits (losses) | 14 | €40k | €39k | €39k | €5k |
| Amounts payable | 17/49 | €61k | €65k | €45k | €67k |
| Amounts payable after one year | 17 | €16k | €26k | €9k | - |
| Amounts payable within one year | 42/48 | €45k | €39k | €34k | €67k |
| Trade debts payable within one year | 44 | €9k | €7k | €3k | €669 |
| Income statement | |||||
| Turnover | 70 | - | - | €143k | - |
| Gross operating margin | 9900 | €50k | €35k | €54k | €48k |
| Operating result | 9901 | €-1k | €3k | €35k | €40k |
| Financial income | 75 | €3k | €93 | - | €2k |
| Financial charges | 65 | €397 | €472 | €1k | €11 |
| Result before taxes | 9903 | €1k | €3k | €34k | €42k |
| Income taxes | 67/77 | - | €3k | - | €6k |
| Net result for the period | 9904 | €1k | €-25 | €34k | €35k |
| Result to be appropriated | 9905 | €1k | €-25 | €34k | €35k |
Legal Structure
| NACE primary | Physiotherapy(86951) |
| Legal form | Private limited company(610) |
| Incorporation | 09-06-2020 |
| Status | Active |
| Postal code | 7190 |
Establishment units
FourD srl
since 20202.303.949.146
Real-estate footprint
Flanders
1
(50%)
Wallonia
1
(50%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 55008C0449/00B000 | Wallonia | 587 m² | 1 · 104 m² | - |
| 23602K0118/00T004 | Flanders | 134 m² | 1 · 105 m² | 11.3 m · 1 fl. |
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
2025
08-10
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 69 days late
2024
31-12
Financial
Back to profitnet €1k
Net result €1k after one loss-making year.
06-10
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 67 days late
2023
31-12
Financial
Weakest financial yearnet €-25 ▼100%
Net result drops to €-25, the lowest in the series; recovery starts the following year.
26-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Liquidity triplescurrent ratio 1.96
Current ratio from 0.76 to 1.96; short-term debt falls from €67k to €34k.
01-12
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 123 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Credit advice
Company registry (CBE)
Activities
Landscape service activities81300Human health activities86905Physiotherapy86951Retail trade47522Production of cinema films59111Motion picture, video and television programme production, sound recording and music publishing activities59112Motion picture, video and television programme production, sound recording and music publishing activities59114Specialised image, lighting and sound technical services90393
Names & trade names
| Legal nameFR | FourD |
Similar companies
SIMON LIEFOOGHE
BE 0793.618.762 · Poperinge
Symphysio
BE 0783.634.195 · Geraardsbergen
MARET PARAMED
BE 0762.933.902 · Orp-Jauche
CHRISTELLE SAUBLAIN
BE 0771.489.993 · Fleurus
SLAM INVEST
BE 0801.201.093 · Incourt